Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New toolkit helps Alzheimer's caregivers decode pain

NCT ID NCT06168604

Knowledge-focused Sponsor: Weill Medical College of Cornell University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a training program called the Pain Identification and Communication Toolkit (PICT) for family caregivers of people with Alzheimer's disease or related dementias. The program teaches caregivers how to spot signs of pain and talk about it with doctors. Researchers will enroll 440 caregivers to see if the training improves pain recognition and communication.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 440 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2023

Expected to finish

Oct 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

CAREGIVER PARTICIPANTS Inclusion Criteria: 1. Age 21 or older 2. Any gender 3. English speaking 4. Cognitively intact (BOMC ≤10) 5. Provides care to a community-dwelling adult with dementia or cognitive impairment who also has a pain diagnosis 6. Care recipient is not enrolled in hospice 7. Visits the care recipient at least weekly 8. Accessible by telephone Exclusion Criteria: 1. Paid caregiver 2. Age 20 or younger 3. Non-English speaking 4. Cognitively impaired 5. Does not provide care to a person with dementia or cognitive impairment who also has a pain diagnosis 6. Currently enrolled in hospice 7. The patient to whom the caregiver provides assistance is enrolled in hospice 8. Visits care recipient less than weekly 9. Not accessible by telephone. PATIENT PARTICIPANTS Inclusion Criteria: 1. Residing in community settings 2. Record of dementia or cognitive impairment 3. Diagnosis of pain 4. Responsive to environment 5. No terminal illness with life expectancy \<6 months 6. Not in active cancer treatment Exclusion Criteria: 1. Lives in a residential facility (such as a nursing home or assisted living) 2. Enrolled in hospice 3. No dementia or cognitive impairment 4. Unresponsive to environment 5. Has terminal illness with life expectancy \<6 months 6. Are in active cancer treatment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alzheimer disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Alzheimer disease Caregiver Burden Chronic Pain chronic pain syndrome Cognitive Dysfunction dementia Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Alzheimer disease Caregiver burden Cognitive impairment Dementia Pain, chronic

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Weill Cornell Medicine

    RECRUITING

    New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.